Matches in Nanopublications for { ?s ?p "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- NP88658.RAs-SGTBv4ItIpWfi9OCB8oyXH4zO2JzznSSKFm0C_iTY130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88658.RAs-SGTBv4ItIpWfi9OCB8oyXH4zO2JzznSSKFm0C_iTY130_provenance.
- NP88693.RAs5c2F0nx2Rk8EtTTV8FOx8uXukU4PTYfeFBkjzkrG6M130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88693.RAs5c2F0nx2Rk8EtTTV8FOx8uXukU4PTYfeFBkjzkrG6M130_provenance.
- NP92274.RAuCjr6VTjVXTMLJT6w41kEY-Ljj3DQn8fqOFb1p2PahY130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92274.RAuCjr6VTjVXTMLJT6w41kEY-Ljj3DQn8fqOFb1p2PahY130_provenance.
- NP90540.RAdaABjokFPmxk_yFGqJ5xhp5xOMJSfiyCjxpy7J5sXHA130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90540.RAdaABjokFPmxk_yFGqJ5xhp5xOMJSfiyCjxpy7J5sXHA130_provenance.
- NP92562.RA7uio3CQa1PkqQT1NLGsiozMwNxioxOj-lygfeQGwnMo130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92562.RA7uio3CQa1PkqQT1NLGsiozMwNxioxOj-lygfeQGwnMo130_provenance.
- NP92272.RAF4lbOji0BnU92v_BQAowZzhD9l8-WiLlzCt3za4Nf18130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92272.RAF4lbOji0BnU92v_BQAowZzhD9l8-WiLlzCt3za4Nf18130_provenance.
- assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP149744.RAWsug737aEcRT2jP2URSlVqtoJgbds86IWpui2nEQSRg130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149744.RAWsug737aEcRT2jP2URSlVqtoJgbds86IWpui2nEQSRg130_provenance.
- NP150372.RAXVY4RlFCEoLWxJQ5yViVY0xCAgU6wf4K4LJBaE3EuB4130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150372.RAXVY4RlFCEoLWxJQ5yViVY0xCAgU6wf4K4LJBaE3EuB4130_provenance.
- NP142229.RAin4uw4MtlEoSKSH_07G-kFkOfq6mqRSiBWMpHuGCSAE130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142229.RAin4uw4MtlEoSKSH_07G-kFkOfq6mqRSiBWMpHuGCSAE130_provenance.
- assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP182427.RAZ34CVVTxsBNP9nb1PA8LbktppeZcwGNjskL9qJiMKEM130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182427.RAZ34CVVTxsBNP9nb1PA8LbktppeZcwGNjskL9qJiMKEM130_provenance.
- NP182428.RASlhdYNDhHhXeUHrTd1LszpLS1cb3JByBl4iincH6ZEY130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182428.RASlhdYNDhHhXeUHrTd1LszpLS1cb3JByBl4iincH6ZEY130_provenance.
- NP182431.RAUYZ0syZyREx8eVhCDBtJa6ORhtUKgIkcINcDBkjsotw130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182431.RAUYZ0syZyREx8eVhCDBtJa6ORhtUKgIkcINcDBkjsotw130_provenance.
- NP182430.RAtQxfpow9508YLICtDdP0-Wgcc2Fm8YLkfon5Qh7lsLU130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182430.RAtQxfpow9508YLICtDdP0-Wgcc2Fm8YLkfon5Qh7lsLU130_provenance.
- NP149749.RA2FsSYDHmeCUjUV8vH1KSbkjxUqboYcJLes0zKqQUHD0130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149749.RA2FsSYDHmeCUjUV8vH1KSbkjxUqboYcJLes0zKqQUHD0130_provenance.
- NP142315.RA_UiTpuJsyjILFCNFT6gEh2fUqupMHD_JWtPiUgEZ6tY130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142315.RA_UiTpuJsyjILFCNFT6gEh2fUqupMHD_JWtPiUgEZ6tY130_provenance.
- NP146057.RAKTMdr6KKz_WccK8LBt2NL7au9DLLk2QTnroRYr-v7hU130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146057.RAKTMdr6KKz_WccK8LBt2NL7au9DLLk2QTnroRYr-v7hU130_provenance.
- NP182432.RANqpEH0A_--0dT-2u-0NO8p7uLa3yCNlOHpbRpvpU3DE130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182432.RANqpEH0A_--0dT-2u-0NO8p7uLa3yCNlOHpbRpvpU3DE130_provenance.
- NP182429.RAyb7ADN208b_cMjTZ7qaClSaUQs0pmhgo4Srsuqkqaq0130_assertion description "[Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182429.RAyb7ADN208b_cMjTZ7qaClSaUQs0pmhgo4Srsuqkqaq0130_provenance.